| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/8756-3282(94)90280-1 |
| P698 | PubMed publication ID | 7980966 |
| P50 | author | Sundeep Khosla | Q42164143 |
| L. Joseph Melton | Q112619624 | ||
| P2093 | author name string | Fitzpatrick LA | |
| Hodgson SF | |||
| Lufkin EG | |||
| P433 | issue | 5 | |
| P921 | main subject | osteoporosis | Q165328 |
| P304 | page(s) | 551-555 | |
| P577 | publication date | 1994-09-01 | |
| P1433 | published in | Bone | Q15755003 |
| P1476 | title | Epidemiology and clinical features of osteoporosis in young individuals | |
| P478 | volume | 15 |
| Q35432980 | Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis |
| Q54940489 | Adequate nutrition status important for bone mineral density improvement in a patient with anorexia nervosa. |
| Q28200809 | Adrenal suppression and osteoporosis after treatment of nasal polyposis |
| Q74024001 | Age-related changes in bone density among healthy Greek males |
| Q24197612 | Bisphosphonates for preventing and treating osteoporosis in men |
| Q36560251 | Bone fragility in men--where are we? |
| Q37161922 | Bone involvement in exogenous hypercortisolism |
| Q37417497 | Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis. |
| Q38221766 | Changes in the degree of mineralization with osteoporosis and its treatment |
| Q34537233 | Clinical characteristics and medication use among premenopausal women with osteoporosis and low BMD: the experience of an osteoporosis referral center |
| Q74587810 | Clodronate is effective in preventing corticosteroid-induced bone loss among asthmatic patients |
| Q41260617 | DXA scanning |
| Q35858255 | Dose-Effectiveness Relationships Determining the Efficacy of Ibandronate for Management of Osteoporosis: A Meta-Analysis |
| Q44614806 | Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound |
| Q81175308 | Effects of physical training on bone mineral density in fertile women with idiopathic osteoporosis |
| Q35643754 | Efficacy of zoledronic acid in treatment of osteoporosis in men and women-a meta-analysis |
| Q34069654 | Evaluation and management of the premenopausal woman with low BMD. |
| Q86031716 | Evaluation of perfusion-related and true diffusion in vertebral bone marrow: a preliminary study |
| Q26827401 | Evidence for the adverse effect of starvation on bone quality: a review of the literature |
| Q46294604 | Fragility fractures in men with idiopathic osteoporosis are associated with undermineralization of the bone matrix without evidence of increased bone turnover |
| Q36065521 | Glucocorticoid-induced osteoporosis: from basic mechanisms to clinical aspects |
| Q82869544 | Glucocorticoid-induced osteoporosis: when and who should we treat? |
| Q45010786 | Idiopathic osteoporosis in premenopausal women |
| Q35091895 | Individual trabeculae segmentation (ITS)-based morphological analysis of high-resolution peripheral quantitative computed tomography images detects abnormal trabecular plate and rod microarchitecture in premenopausal women with idiopathic osteoporos |
| Q37135281 | Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis. |
| Q34993810 | Leg weakness in a patient with lumbar stenosis and adrenal insufficiency |
| Q37190013 | Low-energy fractures without low T-scores characteristic of osteoporosis: a possible bone matrix disorder |
| Q33687994 | Male Skeletal Health and Osteoporosis |
| Q34929054 | Male osteoporosis: clinical approach and management in family practice |
| Q34293831 | Method for cortical bone structural analysis from magnetic resonance images |
| Q33900376 | Osteoporosis Knowledge among Future Healthcare Practitioners: Findings from a Malaysian Public University. |
| Q38017609 | Osteoporosis in young adults: pathophysiology, diagnosis, and management. |
| Q39107524 | Premenopausal Osteoporosis |
| Q34069758 | Premenopausal bone health: osteoporosis in premenopausal women. |
| Q35501419 | Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density |
| Q35550964 | Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice |
| Q28270738 | Recognizing and treating secondary osteoporosis |
| Q58126560 | The microanatomy of trabecular bone in young normal and osteoporotic elderly males |
| Q38074897 | The pathogenesis, treatment and prevention of osteoporosis in men. |
| Q38608906 | The risk benefit ratio of glucocorticoids in SLE: have things changed over the past 40 years? |
| Q37216576 | Treatment of osteoporosis in men with bisphosphonates: rationale and latest evidence |
| Q35551624 | Treatment of premenopausal women with low bone mineral density |
| Q36599658 | Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study |
| Q35549207 | Vertebral fractures and bone mineral density in idiopathic, secondary and corticosteroid associated osteoporosis in men. |
| Q92503476 | Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis |
| Q47306113 | Weight loss, articular pain and bone fractures: neoplastic disease or malabsorption syndrome? |
| Q80186974 | Young patients with hip fracture: a population-based study of bone mass and risk factors for osteoporosis |
| Q77421310 | [Aetiologic features of osteoporosis in male patients aged less than 50 years: study of 28 cases with a comparative series of 30 patients over the age of 50] |
| Q81352205 | [Bone mineral density after treatment for nasal polyposis] |
| Q94463007 | [Indications authorized in Spain of osteoporosis drugs] |
| Q73547820 | [Steroid induced osteoporosis: prevention and treatment] |
Search more.